Harmonised classification and labelling previous targeted consultations

These targeted consultations for CLH proposals are closed. The consultations are launched in case further information is needed on a particular hazard class, or if comments are sought on e.g. a specific additional document.

The comments received during the consultation are available on the Registry of CLH intentions until outcome.

 

There are currently no ongoing consultations.
 
N-(5-chloro-2-isopropylbenzyl)-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide; isoflucypram - 1255734-28-1 United Kingdom Acute Tox. 4, H332,
Skin Sens. 1B, H317,
Aquatic Acute 1, H400,
Aquatic Acute 1, M-factor=10,
Aquatic Chronic 1, H410,
Aquatic Chronic 1, M-factor=1
ATE = 2.2 mg/L
Details